TP-01-HN-106

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameTP-01-HN-106
Drug Alias NameTP01HN106(Talengen Inst Life Sciences)TP-01-HN-106
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesTalengen Inst Life Sciences Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesTalengen Inst Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A